HHS awards $11.9M for Chemical Threat Countermeasures R&D to SRI International
Contract Overview
Contract Amount: $11,897,394 ($11.9M)
Contractor: SRI International
Awarding Agency: Department of Health and Human Services
Start Date: 2006-09-30
End Date: 2019-04-30
Contract Duration: 4,595 days
Daily Burn Rate: $2.6K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 2
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: COUNTERMEASURES AGAINST CHEMICAL THREATS (COUNTERACT) PRECLINICAL DEVELOPMENT FACILITY
Place of Performance
Location: MENLO PARK, SAN MATEO County, CALIFORNIA, 94025
Plain-Language Summary
Department of Health and Human Services obligated $11.9 million to SRI INTERNATIONAL for work described as: COUNTERMEASURES AGAINST CHEMICAL THREATS (COUNTERACT) PRECLINICAL DEVELOPMENT FACILITY Key points: 1. The contract focuses on critical R&D for chemical threat countermeasures. 2. SRI International, a significant research organization, is the awardee. 3. The contract duration is substantial at over 12 years. 4. The award falls under the Research and Development sector.
Value Assessment
Rating: good
The contract value of $11.9M over 12 years suggests a moderate investment in R&D. Benchmarking against similar large-scale R&D contracts would provide further context on its pricing.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating a competitive bidding process. This method generally promotes price discovery and potentially better value for the government.
Taxpayer Impact: Taxpayer funds are being invested in critical research to enhance national security against chemical threats.
Public Impact
Enhances national security by developing countermeasures against chemical threats. Supports advanced scientific research and development capabilities. Potential for future commercialization of developed technologies.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Long contract duration could lead to scope creep or evolving requirements.
- Cost-plus contract type may incentivize higher spending if not closely managed.
Positive Signals
- Addresses a critical national security need.
- Awarded through full and open competition.
- Significant investment in R&D.
Sector Analysis
This contract falls within the Research and Development sector, specifically focusing on physical, engineering, and life sciences. Spending in this area is crucial for innovation and national security, with significant government investment typically seen in areas like defense and health.
Small Business Impact
The contract was awarded to SRI International, a large research organization, and there is no indication of small business participation. Future contracts could explore opportunities for small businesses in specialized areas of this research.
Oversight & Accountability
The contract's long duration and cost-plus nature necessitate robust oversight from the National Institutes of Health to ensure funds are used effectively and milestones are met.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Long contract duration.
- Cost-plus contract type.
- Lack of specific threat details.
- No clear small business involvement.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, ca, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $11.9 million to SRI INTERNATIONAL. COUNTERMEASURES AGAINST CHEMICAL THREATS (COUNTERACT) PRECLINICAL DEVELOPMENT FACILITY
Who is the contractor on this award?
The obligated recipient is SRI INTERNATIONAL.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $11.9 million.
What is the period of performance?
Start: 2006-09-30. End: 2019-04-30.
What specific chemical threats are being addressed by this R&D, and what is the projected timeline for developing effective countermeasures?
The specific chemical threats are not detailed in the provided data. However, the contract's extensive duration (over 12 years) suggests a long-term, complex research effort. The projected timeline for developing effective countermeasures would likely be phased, with preclinical development being the initial focus, followed by further testing and potential deployment stages.
What are the key performance indicators (KPIs) for this contract, and how will SRI International's performance be measured against them?
Key performance indicators are not explicitly stated in the data. Typically, for R&D contracts, KPIs would include successful completion of research phases, achievement of scientific milestones, development of prototypes, and adherence to budget and schedule. Performance measurement would likely involve regular technical reviews, progress reports, and evaluation of scientific outcomes by NIH.
Given the cost-plus fixed fee structure, what mechanisms are in place to control costs and ensure value for taxpayer money?
Cost-plus fixed fee contracts require strong government oversight to manage costs effectively. Mechanisms would include detailed budget reviews, audits of expenditures, negotiation of fee based on performance, and clear definition of allowable costs. The government contracting officer must actively monitor spending and ensure SRI International operates efficiently to achieve the research objectives within the agreed-upon parameters.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: BASIC RESEARCH
Offers Received: 2
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Address: 333 RAVENSWOOD AVE, MENLO PARK, CA, 94025
Business Categories: Category Business, Nonprofit Organization, Not Designated a Small Business
Financial Breakdown
Contract Ceiling: $11,897,394
Exercised Options: $11,897,394
Current Obligation: $11,897,394
Contract Characteristics
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Timeline
Start Date: 2006-09-30
Current End Date: 2019-04-30
Potential End Date: 2019-04-30 00:00:00
Last Modified: 2018-09-11
More Contracts from SRI International
- - NEW Award to Support the Army National Guard Exportable Combat Training Capability (xctc) — $155.5M (Department of the Interior)
- U437D00 Desert OWL Oconus Operational Assessment — $140.8M (Department of Defense)
- 8506396549! Contract, Procurement, and ACQ SPT Svcs — $69.9M (Department of Defense)
- Exportable Combat Training Capability (xctc) Training Services — $60.6M (Department of the Interior)
- Ot8507954814spe7l121f172dp00002 — $60.3M (Department of Defense)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →